The Research and Development team at Eikonizo Therapeutics focuses on designing and synthesizing brain-penetrant small molecules, utilizing in vivo target engagement techniques to identify potential therapeutics. Their primary goal is to develop disease-modifying treatments for neurodegenerative diseases by leveraging advanced translational research and medicinal chemistry.
View all